AMERI Holdings, Inc. | Business Contracts

Employment Agreement between Kevin Coveney and the Company, effective March 13, 2023 (Filed With SEC on February 28, 2023)

Form of RD Pre-Funded Warrant (Filed With SEC on July 26, 2022)

Form of PIPE Preferred Investment Option (Filed With SEC on July 26, 2022)

Exclusive License Agreement, between the Company and Diverse Biotech, Inc. (Diverse), dated March 5, 2021 (Filed With SEC on May 17, 2021)

Development and Clinical Supply Agreement, between the Company and PureForm Global, Inc., dated February 22, 2021 (Filed With SEC on May 17, 2021)

AMENDMENT NO. 1 to TENDER OFFER SUPPORT AGREEMENT AND TERMINATION OF AMALGAMATION AGREEMENT, dated December 18, 2020, by and among Ameri, Jay Pharma Merger Sub, Inc., Jay Pharma... (Filed With SEC on December 18, 2020)

Form of Warrant Amendment (Filed With SEC on July 26, 2022)

Form of Registration Rights Agreement (Filed With SEC on July 26, 2022)

Form of PIPE Securities Purchase Agreement (Filed With SEC on July 26, 2022)

Form of Registered Direct Securities Purchase Agreement (Filed With SEC on July 26, 2022)

Form of Wainwright Warrant (Filed With SEC on July 26, 2022)

Form of RD Preferred Investment Option (Filed With SEC on July 26, 2022)

Form of PIPE Pre-Funded Warrant (Filed With SEC on July 26, 2022)

First Amendment to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (Filed With SEC on July 14, 2022)

Form of Warrant (Filed With SEC on May 11, 2022)

Form of Registration Rights Agreement (Filed With SEC on May 11, 2022)

Certificate of the Designations, Preferences and Rights of Series A Convertible Preferred Stock (Filed With SEC on May 11, 2022)

Form of Securities Purchase Agreement (Filed With SEC on May 11, 2022)

Description of Securities (Filed With SEC on March 31, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on February 15, 2022)

Underwriting Agreement, dated February 11, 2022, by and between Enveric Biosciences, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on February 15, 2022)

MagicMed Stock Option Plan, as amended September 10, 2021 (Filed With SEC on September 17, 2021)

Form of MagicMed Warrant Certificate (Filed With SEC on September 17, 2021)

Employment Agreement between Joseph Tucker and Enveric Biosciences, Inc (Filed With SEC on May 24, 2021)

Amalgamation Agreement, dated May 24, 2021, by and among Enveric Biosciences, Inc., 1306432 B.C. LTD., 1306436 B.C. LTD., and MagicMed Industries, Inc (Filed With SEC on May 24, 2021)

Employment Agreement between Peter Facchini and Enveric Biosciences, Inc (Filed With SEC on May 24, 2021)

Employment Agreement between Jillian Hagel and Enveric Biosciences, Inc (Filed With SEC on May 24, 2021)

Employment Agreement between Carter J. Ward and the Company, effective May 15, 2021 (Filed With SEC on April 12, 2021)

Form of Series B Warrant (Filed With SEC on April 1, 2021)

Assignment and Assumption Agreement (Non-U.S. GVHD Sublicense), dated January 10, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and Tikun Olam IP Ltd (Filed With SEC on April 1, 2021)

Amendment No. 1 to Secured Promissory Note, dated May 6, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc (Filed With SEC on April 1, 2021)

Amendment No. 2 to Secured Promissory Note, dated June 23, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc (Filed With SEC on April 1, 2021)

Amendment No. 3 to Secured Promissory Note, dated August 12, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc (Filed With SEC on April 1, 2021)

Securities Purchase Agreement, dated January 10, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc (Filed With SEC on April 1, 2021)

Amendment No. 2 to Securities Purchase Agreement, dated July 2, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc (Filed With SEC on April 1, 2021)

Amendment No. 3 to Securities Purchase Agreement, dated August 12, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc (Filed With SEC on April 1, 2021)

Assignment and Assumption Agreement (U.S. GVHD Sublicense and Skincare), dated January 10, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and TO Pharmaceuticals USA LLC (Filed With SEC on April 1, 2021)

Amendment No. 1 to Assignment and Assumption Agreement (Non-U.S. GVHD Sublicense), dated August 12, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and Tikun Olam IP Ltd (Filed With SEC on April 1, 2021)

Amendment No. 2 to Assignment and Assumption Agreement (Non-U.S. GVHD Sublicense and Skincare), dated October 2, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and Tikun... (Filed With SEC on April 1, 2021)

Amendment No. 1 to Assignment and Assumption Agreement (U.S. GVHD Sublicense and Skincare), dated August 12, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and TO... (Filed With SEC on April 1, 2021)

Amendment No. 2 to Assignment and Assumption Agreement (U.S. GVHD Sublicense and Skincare), dated October 2, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and TO... (Filed With SEC on April 1, 2021)

License Agreement, dated January 10, 2020, by and among Tikun Olam LLC, Tikun Olam Hemp LLC and Jay Pharma Inc (Filed With SEC on April 1, 2021)

Amendment No. 1 to License Agreement, dated August 12, 2020, by and among Tikun Olam LLC, Tikun Olam Hemp LLC and Jay Pharma Inc (Filed With SEC on April 1, 2021)

Amendment No. 2 to License Agreement, dated October 2, 2020, by and among Tikun Olam LLC, Tikun Olam Hemp LLC and Jay Pharma Inc (Filed With SEC on April 1, 2021)

Secured Promissory Note, dated January 10, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc (Filed With SEC on April 1, 2021)

Description of Securities (Filed With SEC on April 1, 2021)

Form of Registration Rights Agreement (Filed With SEC on February 11, 2021)

Form of Securities Purchase Agreement (Filed With SEC on February 11, 2021)

Form of Warrant (Filed With SEC on February 11, 2021)

Letter Agreement, dated January 11, 2021 (Filed With SEC on January 12, 2021)

Form of Registration Rights Agreement (Filed With SEC on January 12, 2021)

Form of Securities Purchase Agreement (Filed With SEC on January 12, 2021)

Form of Warrant (Filed With SEC on January 12, 2021)

Form of Pre-funded Warrant (Filed With SEC on January 12, 2021)

Employment Agreement, by and between the Company and Robert Wilkins, dated December 22, 2020 (Filed With SEC on January 6, 2021)

Employment Agreement, by and between the Company and David Johnson, dated January 10, 2020 (Filed With SEC on January 6, 2021)

Employment Agreement, by and between the Company and Avani Kanubaddi, dated December 2, 2020 (Filed With SEC on January 6, 2021)

Form of RSU Award Agreement (Filed With SEC on January 6, 2021)

Consulting Agreement, by and between the Company and Barry Kostiner, dated December 29, 2020 (Filed With SEC on January 6, 2021)

Enveric Biosciences, Inc. 2020 Long-Term Equity Incentive Plan (Filed With SEC on January 6, 2021)

Form of Debenture (Filed With SEC on September 11, 2020)

Form of Exchange Agreement (Filed With SEC on September 11, 2020)

TENDER OFFER SUPPORT AGREEMENT AND TERMINATION OF AMALGAMATION AGREEMENT, dated August 12, 2020, by and among Ameri, Jay Pharma Merger Sub, Inc., Jay Pharma Inc., 1236567 B.C.... (Filed With SEC on August 12, 2020)

Form of Pre-Funded Warrant (Filed With SEC on August 3, 2020)

Form of Warrant (Filed With SEC on August 3, 2020)

Form of Securities Purchase Agreement (Filed With SEC on August 3, 2020)

Form of Debenture (Filed With SEC on June 4, 2020)

Form of Securities Purchase Agreement (Filed With SEC on June 4, 2020)

Form of Exchange Agreement (Filed With SEC on June 4, 2020)

Amalgamation Amendment Agreement No. 2, dated May 26, 2020, by and between Ameri Holdings, Inc., Jay Pharma Merger Sub, Inc., Jay Pharma Inc., Jay Pharma ExchangeCo, Inc. and... (Filed With SEC on June 1, 2020)

Amendment No. 2 to Amalgamation Agreement, dated May 26, 2020, by and among Ameri, Jay Pharma Merger Sub, Inc., Jay Pharma Inc., 1236567 B.C. Unlimited Liability Company and Barry... (Filed With SEC on May 28, 2020)

Promissory Note from Sterling National Bank, due May 6, 2022 (Filed With SEC on May 15, 2020)

Form of Series B Warrant, dated May 6, 2020 (Filed With SEC on May 6, 2020)

Form of Amalgamation Amendment Agreement, dated May 6, 2020, by and between AMERI Holdings, Inc., Jay Pharma Merger Sub, Inc., Jay Pharma Inc., Jay Pharma ExchangeCo, Inc. and... (Filed With SEC on May 6, 2020)

Form of Pre-Funded Warrant, dated May 6, 2020 (Filed With SEC on May 6, 2020)

Form of Registration Rights Agreement, dated May 6, 2020 (Filed With SEC on May 6, 2020)

Form of Maturity Extension and Forbearance Agreement, dated May 6, 2020 (Filed With SEC on May 6, 2020)

Description of Securities (Filed With SEC on March 25, 2020)

Secured Promissory Note (Filed With SEC on March 4, 2020)

Note Purchase and Security Agreement (Filed With SEC on March 4, 2020)

Share Purchase Agreement, dated January 10, 2020, by and between AMERI Holdings, Inc. and Ameri100, Inc (Filed With SEC on January 13, 2020)

Form of Convertible Debenture (Filed With SEC on November 25, 2019)

Form of Securities Purchase Agreement (Filed With SEC on November 25, 2019)

Form of Exchange Agreement (Filed With SEC on September 20, 2019)

Corporate Guaranty, dated January 23, 2019, by the Company in favor of North Mill Capital LLC (Filed With SEC on January 25, 2019)

Revolving Credit Master Promissory Note, dated January 23, 2019 (Filed With SEC on January 25, 2019)

Security Agreement, dated January 23, 2019, by and between the Company and North Mill Capital LLC (Filed With SEC on January 25, 2019)

Form of Indemnification Agreement (Filed With SEC on January 25, 2019)

Loan and Security Agreement, dated January 23, 2019, by and between (i) Ameri100 Arizona LLC, (ii) Ameri100 Georgia, Inc., (iii) Ameri100 California, Inc. and (iv) Ameri and... (Filed With SEC on January 25, 2019)

AMERI Holdings, Inc. (89)